Dr. Cristina Gasparetto

An interest in biological sciences and giving back to the community drove me to medical school, but it has been a desire to advance the field of hematologic malignancies, specifically Multiple Myeloma, that brings me to Duke Health. Cancer is a life-altering diagnosis. With a strong, competent team caring for a patient, there can be many success stories. My goal is to empower my patients to understand their diagnosis and how to manage their disease while providing them with many treatment options along the way. Dr. Costa is rated as an Advanced provider by MediFind in the treatment of GTP Cyclohydrolase 1 Deficiency. Her top areas of expertise are Relapsed Refractory Multiple Myeloma (RRMM), Multiple Myeloma, Smoldering Multiple Myeloma, Hereditary Cerebral Amyloid Angiopathy, and Bone Marrow Aspiration.

People in need of a bone marrow transplantation can often be scared or intimidated by what is ahead of them -- my goal, when seeing a new patient, is to devote all the time and effort that is needed to address these emotions. My hope is that after this visit, my patient will feel reassured and hopeful that the Duke team of providers will do all that it can to restore them to health, and allow them to return to their lives. Dr. Horwitz is rated as a Distinguished provider by MediFind in the treatment of GTP Cyclohydrolase 1 Deficiency. His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

Since studying basic immunology prior to beginning my clinical training, I have been deeply interested in applying immunological perspective for the treatment of cancers including hematologic malignancies. Interestingly emerging immunotherapies showed very promising results in recent years. In my clinic, I treat patients with multiple myeloma which is one type of cancer arising from plasma cells. My research will focus on developing early phase clinical protocols utilizing novel cellular therapy approach and also improving the outcomes of blood and marrow transplantation. My ultimate goal is to provide better treatment options than the current standard approach to patients. Dr. Choi is rated as a Distinguished provider by MediFind in the treatment of GTP Cyclohydrolase 1 Deficiency. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.